DrugPatentWatch Database Preview

Institut Biochimique Company Profile

« Back to Dashboard

What is the competitive landscape for INSTITUT BIOCHIMIQUE, and what generic alternatives to INSTITUT BIOCHIMIQUE drugs are available?

INSTITUT BIOCHIMIQUE has two approved drugs.

There are two US patents protecting INSTITUT BIOCHIMIQUE drugs.

There are sixteen patent family members on INSTITUT BIOCHIMIQUE drugs in nine countries.

Summary for Institut Biochimique

International Patents:	16
US Patents:	2
Tradenames:	2
Ingredients:	1
NDAs:	2

Drugs and US Patents for Institut Biochimique

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Institut Biochimique	TIROSINT-SOL	levothyroxine sodium	SOLUTION;ORAL	206977-002	Dec 15, 2016		DISCN	Yes	No
Institut Biochimique	TIROSINT	levothyroxine sodium	CAPSULE;ORAL	021924-003	Oct 13, 2006		RX	Yes	No	7,723,390		Y
Institut Biochimique	TIROSINT-SOL	levothyroxine sodium	SOLUTION;ORAL	206977-008	Dec 15, 2016		DISCN	Yes	No
Institut Biochimique	TIROSINT	levothyroxine sodium	CAPSULE;ORAL	021924-013	Aug 1, 2007		RX	Yes	No	7,723,390		Y
Institut Biochimique	TIROSINT	levothyroxine sodium	CAPSULE;ORAL	021924-008	Oct 2, 2009		RX	Yes	No	7,691,411		Y

International Patents for Institut Biochimique Drugs

Country	Patent Number	Estimated Expiration
Denmark	1433478
Austria	447939
Austria	312621
Japan	2003081870
Germany	60207951

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Inst Biochem
• Institut Biochimique